Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group
about
Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspectiveTreatment of peripheral T-cell lymphoma: are we data driven or driving the data?Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I studyLong-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.Peripheral T-cell lymphoma: review and updates of current management strategiesAutologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigensPrimary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphomaHow to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and managementHematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.Controversies in the treatment of lymphoma with autologous transplantation.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Hematopoietic cell transplantation for lymphomas.Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longPeripheral T-cell lymphomas: a review of current approaches and hopes for the future.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.Investigational drugs for T-cell lymphoma.Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experienceAutologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.An update in management of noncutaneous T-cell lymphomas.Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.Autologous stem cell transplantation for aggressive lymphomas.Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
P2860
Q26998446-4A66A60C-B6F4-45D7-88D9-707A0F378532Q30613674-4E001174-96F8-47F4-B64F-3B5D58521C19Q33394912-4747D8D2-12FB-42DC-BB33-0A6823970813Q33396356-445594B3-69C0-4FA3-B78C-109845A2ED43Q33822764-A3F674DE-BC32-454D-B09B-B6BCA0E0D41FQ34034389-F4C09A7F-A282-4CE8-86D4-CD308088F8C1Q34226010-CD5A6D80-1645-4494-96A8-071BEE413DF0Q34307446-49E7DF08-EBF2-4DDD-941B-92ABBE526955Q34479082-797E3C79-74BF-4964-B587-17A2CEF57348Q35025993-FE5AE7ED-7A86-4044-ABD5-4AC8766DAC55Q35181261-6614BA96-F5BF-4C72-8011-DE8EE65F8734Q35224833-0ED21693-B490-4D46-897D-420DDC3E152CQ35703714-41381D90-1937-4C2E-8CDE-72F6F34037F9Q36283958-8B2CB983-7110-4D12-B0A0-275C9DD28CEBQ36355093-8DF3DC77-3AE0-43CA-96AE-72A52D31F7A2Q36604739-9973D43E-BD1A-406C-99B9-11E5957B39F5Q36907048-66FAA3F8-7F45-4514-A09F-4C78D8F06B01Q36926529-F56CD090-4275-483D-BF0B-494D819DEF14Q37122302-0FC019D6-6B65-43FE-947D-1B6CD7A2125DQ37214534-D7129673-CBA2-44DF-BB30-4943830CCD82Q37271019-69C31FB9-F2C7-4DA2-B036-FF1364F45A7DQ37391571-2579425D-C68F-4B48-9936-9DA38F760E35Q37593800-2A7FB625-0382-44D5-9962-1E7438DAB066Q37809085-073048C4-F206-4357-9358-D915365580B7Q37863688-0A92B87F-F1DF-43FD-B770-A8C008EC4448Q37942817-DA26441B-12B1-4EF5-92AC-25DC8AE01EF4Q38046051-F284BF1F-C6CE-40F3-88F6-7B5C07736E5EQ38113568-67591CEC-95A8-4049-B55F-16462EC6F59AQ38132821-2663DC41-07B8-44F6-A700-5FA25ED58B98Q38198754-1F753C77-D6CE-418E-B9BC-96231DB857A2Q38209433-5E5FCAF4-592D-4F86-80E2-E573B23A328AQ38528166-605A6A0A-7CDC-46DF-B54B-245D288F3971Q38635909-50224A23-2441-430B-A196-B5DB95667965Q38752460-C8056005-AF61-4E81-A1EB-1E7B59A3AF2DQ38949798-C0A6409A-289B-4C60-976C-C604638E0433Q40834336-42A4F8CE-05D4-41CB-A428-F09EFF6F4D2BQ41215812-01D0D326-25B1-4A18-AAB9-084491AB8CDFQ41928592-50ACFDC5-6A08-48E9-A194-6812CB863271Q42357660-638B1C57-1DB3-4B9C-B120-3487D0937FC6Q43473775-6C06FD03-FCBA-49D0-BF6E-EDC795E25B01
P2860
Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@ast
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@en
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@nl
type
label
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@ast
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@en
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@nl
prefLabel
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@ast
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@en
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@nl
P2093
P2860
P3181
P1476
Frontline autologous stem cell ...... from The Gel-Tamo Study Group
@en
P2093
Angel León
Antonio Gutiérrez
Carmen Albo
Eulogio Conde
José Rodríguez
Julián Marín
María Dolores Caballero
Maurizio Bendandi
Reyes Arranz
P2860
P3181
P356
10.1111/J.1600-0609.2007.00856.X
P407
P577
2007-07-01T00:00:00Z